康缘药业：获得参蒲颗粒药品注册证书

Core Viewpoint - Kangyuan Pharmaceutical (600557) has received the drug registration certificate for "Canpu Granules" from the National Medical Products Administration, marking a significant milestone for the company in expanding its product portfolio [1] Company Summary - "Canpu Granules" is an exclusive product of the company, developed based on a clinical experience formula from Professor Tan Yong of Nanjing University of Chinese Medicine Affiliated Hospital, who inherited the academic thoughts of renowned gynecologists Qian Boxuan and Master of Traditional Chinese Medicine Xia Guicheng [1] - The development of "Canpu Granules" involved comprehensive pharmaceutical, pharmacological toxicology studies, and Phase II and III clinical trials, indicating a robust research and development process [1]